My project focuses on analyzing the response of our tissue engineered vascular graft (TEVG) across an aged life span where thrombosis is expected to be an added concern. We are monitoring hemostatic factors while the TEVG scaffold remodels in vivo. The ultimate goal of my work is to ensure that the TEVG will be appropriate across the life.